| Date Filed | Type | Description |
| 10/04/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/23/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/14/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 06/02/2023 |
4
| LEE WILLIS C (COO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 750 shares
@ $0.28, valued at
$210
Bought 28,700 shares
@ $0.29, valued at
$8.3k
|
|
| 05/15/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 03/31/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 03/31/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 01/31/2023 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 01/20/2023 |
4
| ZEN Wei Peu (Director) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 2,000,000 options to buy
@ $0.5, valued at
$1M
|
|
| 01/20/2023 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 01/19/2023 |
4/A
| LEE WILLIS C (COO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Granted 500,000 options
@ $4.5, valued at
$2.3M
|
|
| 01/19/2023 |
8-K
| Unregistered Sales of Equity Securities, Departure of Directors or Certain Officers; Election of Directors; Appointment of Ce... |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2023 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Granted 7,500,000 warrants
@ $4.5, valued at
$33.8M
|
|
| 12/09/2022 |
8-K
| Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits Interactive Data |
| 12/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
8-K
| Quarterly results |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/09/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/31/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/21/2022 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 10/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/17/2022 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 62,500 shares
@ $0.18, valued at
$11.3k
Bought 35,000 shares
@ $0.17, valued at
$6k
|
|
| 10/13/2022 |
4
| Niihara Yutaka (Chairman and CEO) has filed a Form 4 on Emmaus Life Sciences, Inc.|
Txns:
| Bought 5,000 shares
@ $0.09, valued at
$450
Bought 160,000 shares
@ $0.08, valued at
$12.8k
|
|
|